JD is a strong stock and might shoot up after ER, but just take extra caution there's a chance it might retest the support and continue at the bottom blue line and also watch out the RSI.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。